Latest in NHS

Destiny Pharma receives US FDA QIDP designation for novel antibacterial product

Lead drug product in development for the prevention of post-surgical Staphyloccocal infections

Find out more

Ginkgo Datapoints and Apheris launch antibody developability consortium and AbDev AI competition

These efforts build on Ginkgo’s recent collaboration with Tangible Scientific and Inductive Bio, which aimed to advance small molecule drug discovery through AI-driven...
See more

Sustainability that performs: how GEA is building a better future for pharma

By embedding ESG principles into pharmaceutical manufacturing, GEA is delivering measurable sustainability performance without compromising compliance or productivity